Literature DB >> 15611223

Cutting Edge: NF-kappaB-activating kinase-associated protein 1 participates in TLR3/Toll-IL-1 homology domain-containing adapter molecule-1-mediated IFN regulatory factor 3 activation.

Miwa Sasai1, Hiroyuki Oshiumi, Misako Matsumoto, Norimitsu Inoue, Fumitaka Fujita, Makoto Nakanishi, Tsukasa Seya.   

Abstract

TLRs signal the presence of microbial patterns and activate transcription factors. In TLR3 and TLR4, the adapter Toll-IL-1R homology domain-containing adapter molecule (TICAM-1) (also called Toll/IL-1R domain-containing adapter inducing IFN-beta (TRIF)) mediates IFN regulatory factor 3 (IRF3) phosphorylation followed by IFN-beta production. The regulatory subunit TNFR-associated factor family member-associated NF-kappaB activator (TANK) couples with the kinase complex IkappaB kinase-related kinase epsilon/NF-kappaB-activating kinase (NAK) (TANK-binding kinase 1 (TBK1)) that involveTICAM-1-dependent IFN-beta induction. There are several TANK-homologous proteins. We tested whether TICAM-1 binds and coprecipitates with TANK or its family proteins. The results are: 1) the TANK family protein NAK-associated protein 1 (NAP1), but not TANK, coprecipitates withTICAM-1; 2) NAP1 overexpression markedly enhances TBK1-mediated IFN-beta promoter activation; 3) a dominant-negative form, NAP (158-270), suppresses IRF3 activation in response to poly(I:C) or LPS; 4) RNA interference targeting of the NAP1 message results in a failure of poly(I:C)-mediated IRF3 polymerization and IFN-beta production. Thus, NAP1 is the kinase subunit responsible for TLR3/4-mediated IFN-beta induction in the TICAM-1 pathway.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15611223     DOI: 10.4049/jimmunol.174.1.27

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  32 in total

Review 1.  Deciphering the complexity of Toll-like receptor signaling.

Authors:  Renato Ostuni; Ivan Zanoni; Francesca Granucci
Journal:  Cell Mol Life Sci       Date:  2010-07-31       Impact factor: 9.261

2.  Chlamydia muridarum infection elicits a beta interferon response in murine oviduct epithelial cells dependent on interferon regulatory factor 3 and TRIF.

Authors:  Wilbert A Derbigny; Soon-Cheol Hong; Micah S Kerr; M'hamed Temkit; Raymond M Johnson
Journal:  Infect Immun       Date:  2006-12-18       Impact factor: 3.441

Review 3.  TLR3 immunity to infection in mice and humans.

Authors:  Shen-Ying Zhang; Melina Herman; Michael J Ciancanelli; Rebeca Pérez de Diego; Vanessa Sancho-Shimizu; Laurent Abel; Jean-Laurent Casanova
Journal:  Curr Opin Immunol       Date:  2013-01-03       Impact factor: 7.486

4.  Polyubiquitin binding to optineurin is required for optimal activation of TANK-binding kinase 1 and production of interferon β.

Authors:  Catherine E Gleason; Alban Ordureau; Robert Gourlay; J Simon C Arthur; Philip Cohen
Journal:  J Biol Chem       Date:  2011-08-23       Impact factor: 5.157

5.  Analysis of a TIR-less splice variant of TRIF reveals an unexpected mechanism of TLR3-mediated signaling.

Authors:  Ke-Jun Han; Yan Yang; Liang-Guo Xu; Hong-Bing Shu
Journal:  J Biol Chem       Date:  2010-03-03       Impact factor: 5.157

6.  Homo-oligomerization is essential for Toll/interleukin-1 receptor domain-containing adaptor molecule-1-mediated NF-kappaB and interferon regulatory factor-3 activation.

Authors:  Kenji Funami; Miwa Sasai; Hiroyuki Oshiumi; Tsukasa Seya; Misako Matsumoto
Journal:  J Biol Chem       Date:  2008-05-01       Impact factor: 5.157

Review 7.  Sensing of viral infection and activation of innate immunity by toll-like receptor 3.

Authors:  Elisabeth Vercammen; Jens Staal; Rudi Beyaert
Journal:  Clin Microbiol Rev       Date:  2008-01       Impact factor: 26.132

8.  Identification of proangiogenic genes and pathways by high-throughput functional genomics: TBK1 and the IRF3 pathway.

Authors:  Christian Korherr; Hendrik Gille; Rolf Schäfer; Kerstin Koenig-Hoffmann; Johan Dixelius; Kristi A Egland; Ira Pastan; Ulrich Brinkmann
Journal:  Proc Natl Acad Sci U S A       Date:  2006-03-06       Impact factor: 11.205

Review 9.  Immunomodulatory effects of dsRNA and its potential as vaccine adjuvant.

Authors:  Bo Jin; Tao Sun; Xiao-Hong Yu; Chao-Qun Liu; Ying-Xiang Yang; Ping Lu; Shan-Feng Fu; Hui-Bin Qiu; Anthony E T Yeo
Journal:  J Biomed Biotechnol       Date:  2010-07-05

10.  Toll-like receptor-3 activation increases the vulnerability of the neonatal brain to hypoxia-ischemia.

Authors:  Linnea Stridh; Amin Mottahedin; Maria E Johansson; Raul Chavez Valdez; Frances Northington; Xiaoyang Wang; Carina Mallard
Journal:  J Neurosci       Date:  2013-07-17       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.